• A unique collection of 408 kinase inhibitors for high throughput screening (HTS) and high content screening (HCS)
• Bioactivity and safety confirmed by preclinical research and clinical trials
• FDA authentication of some inhibitors
• RTKs, PI3K, Aurora Kinase, CDK, and MEK target inbibitors
• Most are ATP competitive
• Structurally diverse, medicinally active, and cell permeable
• Abundant documentation with structure, IC50, and customer reviews
• Quality inspection report of NMR and HPLC ensure high purity
Documentation Download
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
AbMole Kinase Inhibitor Library Manual